Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Nature Communications|January 28, 2015
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomasLuis Jaime Castro-Vega, Eric Letouzé, Nelly Burnichon, et al.Human Molecular Genetics|December 17, 2013
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomasLuis Jaime Castro-Vega, Alexandre Buffet, Aguirre A De Cubas, et al.Endocrinology|July 20, 2019
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor CulturesMaria Fankhauser, Nicole Bechmann, Michael Lauseker, et al.Journal of Molecular Medicine (Berlin, Germany)|June 14, 2015
Functional and in silico assessment of MAX variants of unknown significanceIñaki Comino-Méndez, Luis J Leandro-García, Guillermo Montoya, et al.Journal of Medical Genetics|January 31, 2020
Germline mutations in the new E1' cryptic exon of the <i>VHL</i> gene in patients with tumours of von Hippel-Lindau disease spectrum or with paragangliomaAlexandre Buffet, Bruna Calsina, Shahida Flores, et al.The Journal of Clinical Endocrinology and Metabolism|January 31, 2019
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or PheochromocytomaAlexandre Buffet, Laurène Ben Aim, Sophie Leboulleux, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 17, 2018
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patientsBruna Calsina, Maria Currás-Freixes, Alexandre Buffet, et al.Environmental Science and Pollution Research International|May 26, 2026
Report of the scientific network Holimitox on succinate dehydrogenase inhibitor (SDHI) pesticides: new insights and challenges with an EcoHealth approach-presentations and round tables from the Holimitox day on November 7, 2024Jean-Marc Bonmatin, François Chamaraux, Séverine Jean, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, et al.Theranostics|August 15, 2019
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paragangliomaBruna Calsina, Luis Jaime Castro-Vega, Rafael Torres-Pérez, et al.Pageof 11